Human MIP-3β/ELC/CCL19(Macrophage Inflammatory Protein 3β) ELISA Kit

The Human MIP-3Β/ELC/CCL19 (Macrophage Inflammatory Protein 3Β) ELISA Kit is a highly sensitive and specific assay designed to detect and quantify the levels of MIP-3Β/ELC/CCL19 in human serum, plasma, and cell culture supernatants. This kit is based on the sandwich enzyme-linked immunosorbent assay (ELISA) principle, which utilizes two specific antibodies that recognize different epitopes of the target protein. The kit includes all the necessary reagents and components to perform the assay, including pre-coated plates, detection antibodies, standards, and buffers.

The MIP-3Β/ELC/CCL19 protein is a chemokine that plays a crucial role in the recruitment and activation of immune cells, particularly dendritic cells and T cells, to sites of inflammation and infection. Elevated levels of MIP-3Β/ELC/CCL19 have been associated with various inflammatory and autoimmune diseases, such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. Therefore, the accurate measurement of MIP-3Β/ELC/CCL19 levels in biological samples is essential for understanding the pathogenesis of these diseases and developing effective therapeutic strategies.

The Human MIP-3Β/ELC/CCL19 ELISA Kit has a detection range of 15.6-1000 pg/mL and a sensitivity of 7.8 pg/mL. The assay is easy to perform, with a total assay time of 3 hours and 30 minutes. The kit has been validated for use with various sample types, including serum, plasma, and cell culture supernatants, and has shown excellent intra- and inter-assay precision and accuracy. The results obtained from this kit can be used to monitor disease progression, evaluate treatment efficacy, and identify potential biomarkers for various inflammatory and autoimmune diseases.